Literature DB >> 22100472

Effects of terlipressin in a rat model of severe uncontrolled hemorrhage via liver injury.

Basak Bayram1, Nil Hocaoglu, Rıdvan Atilla, Sule Kalkan.   

Abstract

BACKGROUND: Animal experiments and clinical studies have shown that vasopressin infusion in cases of uncontrolled hemorrhagic shock is a promising treatment. However, there are only a few studies regarding the application of terlipressin in hemorrhagic cases. This study was designed to evaluate the effects of terlipressin vs controlled fluid resuscitation on hemodynamic variables and abdominal bleeding in a rat model of uncontrolled hemorrhage via liver injury.
METHODS: A total of 21 average weight 250 ± 30 g Wistar rats were used. A midline celiotomy was performed, and approximately 65% of the median and left lateral lobes were removed with sharp dissection. After creation of the liver injury, rats were randomized into 1 of 3 resuscitation groups, the control group, Lactated Ringer's (LR) group, and terlipressin group, with 7 rats in each group. Blood samples were taken from rats for arterial blood gas analysis. At the end of the experiments, free intraperitoneal blood was collected on preweighed pieces of cotton, and the amount of free blood was determined by the difference in wet and dry weights.
RESULTS: In response to resuscitation, the terlipressin group demonstrated a significant elevation in mean arterial pressure (MAP). Blood loss was greater in the LR group compared with the control group (12.8 ± 1.9 mL vs 8.2 ± 0.7 mL, P < .05). At the end of the experiments, 5 rats in the control group, 5 in the LR group, and 2 in the terlipressin group died. The average survival rates were 28.6%, 28.6%, and 71.4%, respectively.
CONCLUSIONS: Compared with the control group, intravenous terlipressin bolus after liver injury contributed to an increase in MAP and survival rates without increasing abdominal bleeding.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22100472     DOI: 10.1016/j.ajem.2011.09.007

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  7 in total

Review 1.  A global perspective on vasoactive agents in shock.

Authors:  Djillali Annane; Lamia Ouanes-Besbes; Daniel de Backer; Bin DU; Anthony C Gordon; Glenn Hernández; Keith M Olsen; Tiffany M Osborn; Sandra Peake; James A Russell; Sergio Zanotti Cavazzoni
Journal:  Intensive Care Med       Date:  2018-06-04       Impact factor: 17.440

2.  Potential early predictors for outcomes of experimental hemorrhagic shock induced by uncontrolled internal bleeding in rats.

Authors:  Zaid A Abassi; Marina Okun-Gurevich; Niroz Abu Salah; Hoda Awad; Yossi Mandel; Gadi Campino; Ahmad Mahajna; Giora Z Feuerstein; Mike Fitzpatrick; Aaron Hoffman; Joseph Winaver
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240

Review 3.  Vasopressin in hemorrhagic shock: a systematic review and meta-analysis of randomized animal trials.

Authors:  Andrea Pasquale Cossu; Paolo Mura; Lorenzo Matteo De Giudici; Daniela Puddu; Laura Pasin; Maurizio Evangelista; Theodoros Xanthos; Mario Musu; Gabriele Finco
Journal:  Biomed Res Int       Date:  2014-09-01       Impact factor: 3.411

4.  Comparison of normal saline, hypertonic saline albumin and terlipressin plus hypertonic saline albumin in an infant animal model of hypovolemic shock.

Authors:  Javier Urbano; Rafael González; Jorge López; María J Solana; José M Bellón; Marta Botrán; Ana García; Sarah N Fernández; Jesús López-Herce
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

5.  Effects of terlipressin as early treatment for protection of brain in a model of haemorrhagic shock.

Authors:  Keila Kazue Ida; Denise Aya Otsuki; Adolfo Toshiro Cotarelli Sasaki; Emilyn Silva Borges; Letícia Urbano Cardoso Castro; Talita Rojas Sanches; Maria-Heloisa Massola Shimizu; Lúcia Conceição Andrade; José-Otávio Costa Auler; Alex Dyson; Kenneth John Smith; Joel Avancini Rocha Filho; Luiz-Marcelo Sá Malbouisson
Journal:  Crit Care       Date:  2015-03-13       Impact factor: 9.097

6.  Addition of terlipressin to initial volume resuscitation in a pediatric model of hemorrhagic shock improves hemodynamics and cerebral perfusion.

Authors:  Javier Gil-Anton; Victoria E Mielgo; Carmen Rey-Santano; Lara Galbarriatu; Carlos Santos; Maria Unceta; Yolanda López-Fernández; Silvia Redondo; Elvira Morteruel
Journal:  PLoS One       Date:  2020-07-02       Impact factor: 3.240

7.  Vasopressin analog terlipressin attenuates kidney injury in hemorrhagic shock.

Authors:  Letícia Urbano Cardoso de Castro; Keila Kazue Ida; Denise Aya Otsuki; Talita Rojas Sanches; Rildo A Volpini; Emilyn da Silva Borges; Luiz-Marcelo Sá Malbouisson; Lúcia Andrade
Journal:  Trauma Surg Acute Care Open       Date:  2016-09-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.